One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles

Chien Han Kao, Jaw Yuan Wang, Kuo Hsiang Chuang, Chih Hung Chuang, Ta Chun Cheng, Yuan Chin Hsieh, Yun long Tseng, Bing Mae Chen, Steve R. Roffler, Tian Lu Cheng

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Methoxy PEGylated nanoparticles (mPEG-NPs) are increasingly used for cancer imaging and therapy. Here we describe a general and simple approach to confer tumor tropism to any mPEG-NP. We demonstrate this approach with humanized bispecific antibodies (BsAbs) that can bind to both mPEG molecules on mPEG-NPs and to EGFR or HER2 molecules overexpressed on the surface of cancer cells. Simple mixing of BsAbs with mPEG-NPs can mediate preferential binding of diverse mPEG-NPs to cancer cells that overexpress EGFR or HER2 under physiological conditions and significantly increase cancer cell killing by liposomal doxorubicin to EGFR+ and HER2+ cancer cells. BsAbs modification also enhanced accumulation of fluorescence-labeled NPs and significantly increased the anticancer activity of drug-loaded NPs to antigen-positive human tumors in a mouse model. Anti-mPEG BsAbs offer a simple one-step method to confer tumor specificity to mPEG-NPs for enhanced tumor accumulation and improved therapeutic efficacy.

Original languageEnglish
Pages (from-to)9930-9940
Number of pages11
JournalBiomaterials
Volume35
Issue number37
DOIs
Publication statusPublished - Dec 1 2014

Fingerprint

Bispecific Antibodies
Antibodies
Nanoparticles
Tumors
Cells
Neoplasms
Therapeutics
Molecules
Antigens
Antibodies, Monoclonal, Humanized
Tropism
Fluorescence
Imaging techniques
Pharmaceutical Preparations

Keywords

  • Bispecific antibody
  • Cancer imaging
  • Methoxy poly(ethylene glycol)
  • PEGylated nanoparticle
  • Targeted therapy

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics
  • Medicine(all)

Cite this

One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles. / Kao, Chien Han; Wang, Jaw Yuan; Chuang, Kuo Hsiang; Chuang, Chih Hung; Cheng, Ta Chun; Hsieh, Yuan Chin; Tseng, Yun long; Chen, Bing Mae; Roffler, Steve R.; Cheng, Tian Lu.

In: Biomaterials, Vol. 35, No. 37, 01.12.2014, p. 9930-9940.

Research output: Contribution to journalArticle

Kao, Chien Han ; Wang, Jaw Yuan ; Chuang, Kuo Hsiang ; Chuang, Chih Hung ; Cheng, Ta Chun ; Hsieh, Yuan Chin ; Tseng, Yun long ; Chen, Bing Mae ; Roffler, Steve R. ; Cheng, Tian Lu. / One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles. In: Biomaterials. 2014 ; Vol. 35, No. 37. pp. 9930-9940.
@article{73ae3b9811f84750889d3fba19993ba1,
title = "One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles",
abstract = "Methoxy PEGylated nanoparticles (mPEG-NPs) are increasingly used for cancer imaging and therapy. Here we describe a general and simple approach to confer tumor tropism to any mPEG-NP. We demonstrate this approach with humanized bispecific antibodies (BsAbs) that can bind to both mPEG molecules on mPEG-NPs and to EGFR or HER2 molecules overexpressed on the surface of cancer cells. Simple mixing of BsAbs with mPEG-NPs can mediate preferential binding of diverse mPEG-NPs to cancer cells that overexpress EGFR or HER2 under physiological conditions and significantly increase cancer cell killing by liposomal doxorubicin to EGFR+ and HER2+ cancer cells. BsAbs modification also enhanced accumulation of fluorescence-labeled NPs and significantly increased the anticancer activity of drug-loaded NPs to antigen-positive human tumors in a mouse model. Anti-mPEG BsAbs offer a simple one-step method to confer tumor specificity to mPEG-NPs for enhanced tumor accumulation and improved therapeutic efficacy.",
keywords = "Bispecific antibody, Cancer imaging, Methoxy poly(ethylene glycol), PEGylated nanoparticle, Targeted therapy",
author = "Kao, {Chien Han} and Wang, {Jaw Yuan} and Chuang, {Kuo Hsiang} and Chuang, {Chih Hung} and Cheng, {Ta Chun} and Hsieh, {Yuan Chin} and Tseng, {Yun long} and Chen, {Bing Mae} and Roffler, {Steve R.} and Cheng, {Tian Lu}",
year = "2014",
month = "12",
day = "1",
doi = "10.1016/j.biomaterials.2014.08.032",
language = "English",
volume = "35",
pages = "9930--9940",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier Science Ltd",
number = "37",

}

TY - JOUR

T1 - One-step mixing with humanized anti-mPEG bispecific antibody enhances tumor accumulation and therapeutic efficacy of mPEGylated nanoparticles

AU - Kao, Chien Han

AU - Wang, Jaw Yuan

AU - Chuang, Kuo Hsiang

AU - Chuang, Chih Hung

AU - Cheng, Ta Chun

AU - Hsieh, Yuan Chin

AU - Tseng, Yun long

AU - Chen, Bing Mae

AU - Roffler, Steve R.

AU - Cheng, Tian Lu

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Methoxy PEGylated nanoparticles (mPEG-NPs) are increasingly used for cancer imaging and therapy. Here we describe a general and simple approach to confer tumor tropism to any mPEG-NP. We demonstrate this approach with humanized bispecific antibodies (BsAbs) that can bind to both mPEG molecules on mPEG-NPs and to EGFR or HER2 molecules overexpressed on the surface of cancer cells. Simple mixing of BsAbs with mPEG-NPs can mediate preferential binding of diverse mPEG-NPs to cancer cells that overexpress EGFR or HER2 under physiological conditions and significantly increase cancer cell killing by liposomal doxorubicin to EGFR+ and HER2+ cancer cells. BsAbs modification also enhanced accumulation of fluorescence-labeled NPs and significantly increased the anticancer activity of drug-loaded NPs to antigen-positive human tumors in a mouse model. Anti-mPEG BsAbs offer a simple one-step method to confer tumor specificity to mPEG-NPs for enhanced tumor accumulation and improved therapeutic efficacy.

AB - Methoxy PEGylated nanoparticles (mPEG-NPs) are increasingly used for cancer imaging and therapy. Here we describe a general and simple approach to confer tumor tropism to any mPEG-NP. We demonstrate this approach with humanized bispecific antibodies (BsAbs) that can bind to both mPEG molecules on mPEG-NPs and to EGFR or HER2 molecules overexpressed on the surface of cancer cells. Simple mixing of BsAbs with mPEG-NPs can mediate preferential binding of diverse mPEG-NPs to cancer cells that overexpress EGFR or HER2 under physiological conditions and significantly increase cancer cell killing by liposomal doxorubicin to EGFR+ and HER2+ cancer cells. BsAbs modification also enhanced accumulation of fluorescence-labeled NPs and significantly increased the anticancer activity of drug-loaded NPs to antigen-positive human tumors in a mouse model. Anti-mPEG BsAbs offer a simple one-step method to confer tumor specificity to mPEG-NPs for enhanced tumor accumulation and improved therapeutic efficacy.

KW - Bispecific antibody

KW - Cancer imaging

KW - Methoxy poly(ethylene glycol)

KW - PEGylated nanoparticle

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84907260836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907260836&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2014.08.032

DO - 10.1016/j.biomaterials.2014.08.032

M3 - Article

C2 - 25212525

AN - SCOPUS:84907260836

VL - 35

SP - 9930

EP - 9940

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 37

ER -